Epignostix
Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.
2
Funding Rounds
$9.4m
Money raised
Overview
Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.
- Website:
- Business model: B2B
- Headquarters: Heidelberg
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Epignostix has raised a total of $9.4m in funding over 2 rounds.
Key Insights:
- Epignostix July 2024 Seed Funding Round: $4.7m
- Epignostix July 2024 Seed Funding Round: $4.7m
Epignostix July 2024 Seed Funding Round
$4.7m
Epignostix July 2024 Seed Funding Round
$4.7m
Industries
Epignostix is active in the following industries: